Latest studies show a link between diabetes and brain conditions, such as Alzheimer’s disease and Parkinson’s disease – health issues that are becoming more common
Ultrahuman has raised $17.5m in a Series B financing round for its wearable glucose tracking technology. The India-based company is the developer of Ultrahuman Cyborg –
An education campaign has helped to “significantly” reduce the number of recurrent emergency callouts across the East Midlands to people with diabetes experiencing hypoglycaemia. The
Diabetes UK’s annual Type 1 and Tech conference takes place online on 16 October 10am-2pm. The event is free and open to anyone affected by
People with Type 2 diabetes from the south coast of England are invited to participate in an exercise project. Participants need to be registered with a
Eli Lilly has received FDA approval and expanded labelling for its Lyumjev rapid-acting insulin. Lyumjev is a novel formulation of insulin lispro for speeding up
Fractyl Health has activated the 10th clinical site in its REVITA-T2Di trial in the United States and Europe. The trial is a prospective, randomised, double-blind,
People with a rare form of diabetes may receive better treatment and discover whether their children are affected under new plans from NHS England, The Guardian reports.
The United States Preventive Services Task Force recommends people from the age of 35 who are overweight or obese should be screened for prediabetes and
On 14 July Eli Lilly and Company announced the acquisition of Protomer Technologies (“Protomer”), a private biotech company. Protomer’s proprietary peptide- and protein-engineering platform is
